Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Metastatic Melanoma|Metastatic Breast Cancer|Advanced Renal Cell Carcinoma|Squamous Cell Carcinoma of Head and Neck|Non-small Cell Lung Cancer Stage III|Healthy
Interventions: DIAGNOSTIC_TEST: single arm
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Collaborators: Fondazione IRCCS ISTITUTO NAZIONALE TUMORI